Revelation Biosciences (REVB)
(Delayed Data from NSDQ)
$0.90 USD
-0.01 (-1.21%)
Updated Sep 13, 2024 03:59 PM ET
After-Market: $0.90 0.00 (0.11%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -3.16 |
EPS Last Quarter | -1.54 |
Last EPS Surprise | 14.92% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -12.46 |
Next Year | -6.20 |
EPS (TTM) | -24.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -3.16 | -2.43 | -12.46 | -6.20 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -3.16 | -2.43 | -12.46 | -6.20 |
High Estimate | -1.59 | -0.85 | -8.60 | -5.22 |
Low Estimate | -4.73 | -4.00 | -16.32 | -7.18 |
Year ago EPS | -12.31 | -8.33 | -36.96 | -12.46 |
Year over Year Growth Est. | 74.33% | 70.83% | 66.29% | 50.24% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -3.16 | -2.43 | -12.46 | -6.20 |
7 Days Ago | -3.16 | -2.43 | -12.46 | -6.20 |
30 Days Ago | -3.16 | -2.43 | -12.46 | -6.20 |
60 Days Ago | -2.09 | -1.54 | -7.54 | -5.24 |
90 Days Ago | -2.09 | -1.54 | -7.54 | -5.24 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -3.16 | -2.43 | -12.46 | -6.20 |
Zacks Consensus Estimate | -3.16 | -2.43 | -12.46 | -6.20 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.54 | -2.46 | -8.33 | -12.31 | NA |
Estimate | -1.81 | -5.39 | -10.94 | -9.01 | NA |
Difference | 0.27 | 2.93 | 2.61 | -3.30 | 0.63 |
Surprise | 14.92% | 54.36% | 23.86% | -36.67% | 14.12% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more